(1350074) To Fuel Up or Press On? Fluids Versus Vasopressors in the Management of Shock

Location: Congress Digital

Bonus CE Session Moderator(s)

Ashish Khanna, MD, MS, FCCP, FASA

Anesthesiologist & Intensivist, Associate Professor of Anesthesiology
Wake Forest Baptist Medical Center
Winston Salem, North Carolina
Seth Bauer, PharmD, FCCM

Clinical Pharmacist
Cleveland Clinic
Lyndhurst, Ohio

Disclosure(s):

Ashish Khanna, MD, MS, FCCP, FASA: Edwards Lifesciences: Advisory Board (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting fees or other remuneration (Ongoing), Contracted Research (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); GE Healthcare: Consultant (Ongoing); Medtronic Inc: Advisory Board (Ongoing); Philips Healthcare: Advisory Board (Ongoing), Scientific Advisory Board (Ongoing); Trevena: Consultant (Ongoing)

Seth Bauer, PharmD, FCCM: No relevant financial relationship(s) to disclose.

This session will focus on the rationale for and benefits of an early vasopressor versus additional fluid approach to the management of shock and the role of new therapies in the management of refractory shock.

Learning Objectives:

Discuss the rationale for and benefits of administration of additional fluids versus early vasopressors for the management of shock
Debate the use of early vasopressors versus a fluid-restrictive approach to the management of shock
Evaluate the role of new and adjunctive therapies for the management of refractory shock